Evaluating the Safety and Immune Response of DNA/MVA Vaccines in HIV-1-Infected Young Adults Taking Anti-HIV Medications

NCT01909414 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: GEO-D03 DNA Vaccine
BIOLOGICAL: MVA/HIV62B Vaccine
BIOLOGICAL: Placebo for DNA GEO-D03
BIOLOGICAL: Placebo for MVA/HIV62B Vaccine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)